Rofecoxib Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Merck, Wuhan Xinxin Jiali Biotechnology, Pfizer) | Forecast to 2025

BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Rofecoxib Market” Research Report 2020 provides an in-depth analysis of the Rofecoxib with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Rofecoxib on the basis of a number of criteria, such as the product type, application, and its geographical presence.

Global Rofecoxib Market Overview:

This report studies the Global Rofecoxib Market over the forecast period of 2020 to 2025. The Global Rofecoxib Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.

Rofecoxib is a COX-2 selective Nonsteroidal Anti-Inflammatory Drug (NSAID). Rofecoxib gained widespread use among physicians treating patients with arthritis and other conditions causing chronic or acute pain. Worldwide, over 80 million people were prescribed rofecoxib at some time. In 2005 the FDA issued a memo concluding that data from large long-term controlled clinical trials do not clearly demonstrate that COX-2 selective agents have a greater risk of serious CV events than non-selective NSAIDs. The FDA reinforced this position in 2015, stating that the available data support a dose and duration dependent class effect of an increased risk of serious adverse cardiovascular events for COX-2 selective and non-selective NSAIDs.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273455 .

The Global Rofecoxib Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Rofecoxib Market is sub-segmented into Oral Suspension, Tablet-Form and others. On the basis of Application, the Global Rofecoxib Market is classified into Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Acute Pain Conditions, Migraine/Dysmenorrhea and others.

In terms of the geographic analysis, The Rofecoxib Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Rofecoxib Market ecosystem results in the increasing adoption of these systems in North America.

Latest Medical Industry News:

Merck (May 27, 2020) - Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19 - Merck, a leading science and technology company, and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to Phase 1 clinical trials.

“Vaccine manufacturing is extremely complicated, so we are collaborating on a process development approach to accelerate manufacturing of Baylor’s Covid-19 vaccine candidates,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “To fight this pandemic, we will need to produce an unprecedented amount of vaccine in a very short period of time, and we need as many approaches as possible to be successful.”

There are no standard manufacturing templates or processes due to the complexity and diversity of vaccine modalities, which makes production a challenge for every organization racing to develop a safe and effective Covid-19 vaccine. Using key learnings from their ongoing collaboration on a schistosomiasis vaccine, Merck, along with researchers at Baylor College of Medicine and the Texas Children’s Hospital Center for Vaccine Development, is optimizing the production processes to advance two Covid-19 vaccine candidates, including the CoV RBD219-N1 vaccine candidate expected to enter clinical trials later this year. Merck will help to accelerate their suitability for large-scale manufacturing. This collaboration will focus on improvements to production efficiency, yield, robustness, scalability and costs.

“Our initial collaboration with Merck built an important and critical framework for us to quickly validate and ready the production of our portfolio of neglected tropical disease vaccines for global access,” said Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development, alongside Dr. Maria Elena Bottazzi.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Rofecoxib Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273455/single .

Top Leading Key in Players Global Rofecoxib Market: Merck, Chengdu Meinkai Chemical, Wuhan Xinxin Jiali Biotechnology, Hubei TuoChu Kang Yuan Pharmaceutical Chemical, Pfizer, Tremeau and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

With the presence of a large pool of participants, the Global Rofecoxib Market is displaying a highly competitive business landscape, finds a new research report by Business Industry Reports (BIR). Merck, Chengdu Meinkai Chemical, Wuhan Xinxin Jiali Biotechnology, Hubei TuoChu Kang Yuan Pharmaceutical Chemical, Pfizer, Tremeau are some of the key vendors of Rofecoxib across the world. These players across Rofecoxib Market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products.

Region segment: Rofecoxib Market report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Rofecoxib in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273455 .

Major Points in Table of Contents:

Global Rofecoxib Market Report 2020

1 Rofecoxib Product Definition

2 Global Rofecoxib Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Rofecoxib Shipments

2.2 Global Manufacturer Rofecoxib Business Revenue

2.3 Global Rofecoxib Market Overview

2.4 COVID-19 Impact on Rofecoxib Industry

3 Manufacturer Rofecoxib Business Introduction

3.1 Merck Rofecoxib Business Introduction

3.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Business Introduction

3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Business Introduction

3.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Business Introduction

3.5 Pfizer Rofecoxib Business Introduction

3.6 Tremeau Rofecoxib Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.